|
Volumn 31, Issue 17, 2013, Pages
|
Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using177lutetium-DOTATATE
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHROMOGRANIN;
CHROMOGRANIN A;
LUTETIUM 177;
LUTETIUM 177 DOTATATE;
PENTETREOTIDE IN 111;
SOMATOSTATIN RECEPTOR;
SYNAPTOPHYSIN;
UNCLASSIFIED DRUG;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
CYTOREDUCTIVE SURGERY;
EXTERNAL BEAM RADIOTHERAPY;
EYE DISCOMFORT;
EYE EXAMINATION;
HISTOPATHOLOGY;
HUMAN;
INFERIOR OBLIQUE MUSCLE;
LYMPH VESSEL METASTASIS;
MALE;
MESENTERY LYMPH NODE;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
NEUROENDOCRINE TUMOR;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPHTHALMOLOGIST;
ORBIT METASTASIS;
PEPTIDE RECEPTOR RADIOLABELED THERAPY;
PRIORITY JOURNAL;
RADIOISOTOPE THERAPY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SMALL BOWEL NEUROENDOCRINE CARCINOID TUMOR;
SMALL INTESTINE CANCER;
SMALL INTESTINE OBSTRUCTION;
SMALL INTESTINE RESECTION;
AGED;
HUMANS;
LUTETIUM;
MALE;
NEUROENDOCRINE TUMORS;
OCTREOTIDE;
ORBITAL NEOPLASMS;
ORGANOMETALLIC COMPOUNDS;
RADIOISOTOPES;
RADIOPHARMACEUTICALS;
|
EID: 84890507772
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.45.8612 Document Type: Article |
Times cited : (11)
|
References (19)
|